These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17239638)

  • 1. Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma.
    Richter K; Grönke L; Janicki S; Maus J; Jörres RA; Magnussen H
    Pulm Pharmacol Ther; 2008; 21(1):61-6. PubMed ID: 17239638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
    Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen.
    Davis BE; Todd DC; Cockcroft DW
    J Allergy Clin Immunol; 2005 Oct; 116(4):768-72. PubMed ID: 16210049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S; Liu N; Dass SB; Reiss TF
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
    Anderson SD; Brannan JD; Perry CP; Caillaud C; Seale JP
    J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction.
    Mastruzzo C; Contrafatto MR; Crimi C; Palermo F; Vancheri C; Crimi N
    Respir Med; 2010 Oct; 104(10):1417-24. PubMed ID: 20471234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.
    Twentyman OP; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1993 Jun; 91(6):1169-78. PubMed ID: 8099592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
    Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
    Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Montelukast-free interval before inhalational bronchial allergen provocation].
    Riffelmann FW; Droste G; Lauter H; Köhler D
    Pneumologie; 2003 Aug; 57(8):429-32. PubMed ID: 12928982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
    Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
    Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.